112 related articles for article (PubMed ID: 11033885)
1. [Listeria monocytogenes: a dangerous pathogen used as a vector for the new generation of vaccines].
Tkachuk MV; Iarovinskiĭ FO; Tonevitskiĭ AG
Vopr Med Khim; 2000; 46(3):256-64. PubMed ID: 11033885
[TBL] [Abstract][Full Text] [Related]
2. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
[TBL] [Abstract][Full Text] [Related]
3. Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics.
Wallecha A; Carroll KD; Maciag PC; Rivera S; Shahabi V; Paterson Y
Adv Appl Microbiol; 2009; 66():1-27. PubMed ID: 19203646
[TBL] [Abstract][Full Text] [Related]
4. Listeria monocytogenes as an alternative vaccine vector for HIV.
Mata M; Paterson Y
Arch Immunol Ther Exp (Warsz); 2000; 48(3):151-62. PubMed ID: 10912619
[TBL] [Abstract][Full Text] [Related]
5. Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease.
Weiskirch LM; Paterson Y
Immunol Rev; 1997 Aug; 158():159-69. PubMed ID: 9314084
[TBL] [Abstract][Full Text] [Related]
6. Listeria-based vaccines for cancer treatment.
Paterson Y; Maciag PC
Curr Opin Mol Ther; 2005 Oct; 7(5):454-60. PubMed ID: 16248280
[TBL] [Abstract][Full Text] [Related]
7. What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumors.
Hussain SF; Paterson Y
Cancer Immunol Immunother; 2005 Jun; 54(6):577-86. PubMed ID: 15650885
[TBL] [Abstract][Full Text] [Related]
8. Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine.
Sewell DA; Douven D; Pan ZK; Rodriguez A; Paterson Y
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):92-7. PubMed ID: 14732776
[TBL] [Abstract][Full Text] [Related]
9. Listeria as a vaccine vector.
Bruhn KW; Craft N; Miller JF
Microbes Infect; 2007 Aug; 9(10):1226-35. PubMed ID: 17719258
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis and immunology of Listeria monocytogenes.
Schlech WF
Pathol Biol (Paris); 1996 Nov; 44(9):775-82. PubMed ID: 8977900
[TBL] [Abstract][Full Text] [Related]
11. Live-attenuated Listeria-based immunotherapy.
Rothman J; Paterson Y
Expert Rev Vaccines; 2013 May; 12(5):493-504. PubMed ID: 23659298
[TBL] [Abstract][Full Text] [Related]
12. Promises and challenges for the development of Listeria monocytogenes-based immunotherapies.
Brockstedt DG; Dubensky TW
Expert Rev Vaccines; 2008 Sep; 7(7):1069-84. PubMed ID: 18767955
[TBL] [Abstract][Full Text] [Related]
13. Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy.
Singh R; Paterson Y
Expert Rev Vaccines; 2006 Aug; 5(4):541-52. PubMed ID: 16989634
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
Loeffler DI; Schoen CU; Goebel W; Pilgrim S
Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
[TBL] [Abstract][Full Text] [Related]
15. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
16. Advances in the development of bacterial vector technology.
Kochi SK; Killeen KP; Ryan US
Expert Rev Vaccines; 2003 Feb; 2(1):31-43. PubMed ID: 12901595
[TBL] [Abstract][Full Text] [Related]
17. Early infection termination affects number of CD8+ memory T cells and protective capacities in listeria monocytogenes-infected mice upon rechallenge.
Tseng KE; Chung CY; H'ng WS; Wang SL
J Immunol; 2009 Apr; 182(8):4590-600. PubMed ID: 19342633
[TBL] [Abstract][Full Text] [Related]
18. Listeria--review of epidemiology and pathogenesis.
Ramaswamy V; Cresence VM; Rejitha JS; Lekshmi MU; Dharsana KS; Prasad SP; Vijila HM
J Microbiol Immunol Infect; 2007 Feb; 40(1):4-13. PubMed ID: 17332901
[TBL] [Abstract][Full Text] [Related]
19. Fine-tuning the safety and immunogenicity of Listeria monocytogenes-based neonatal vaccine platforms.
Loeffler DI; Smolen K; Aplin L; Cai B; Kollmann TR
Vaccine; 2009 Feb; 27(6):919-27. PubMed ID: 19059297
[TBL] [Abstract][Full Text] [Related]
20. Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination.
Liau LM; Jensen ER; Kremen TJ; Odesa SK; Sykes SN; Soung MC; Miller JF; Bronstein JM
Cancer Res; 2002 Apr; 62(8):2287-93. PubMed ID: 11956085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
